Masahiro Ieko Selected Research

Masahiro Ieko Research Topics

Disease

18	Hemorrhage 03/2022 - 01/2006
18	Thrombosis (Thrombus) 04/2021 - 12/2002
13	Hemophilia A (Haemophilia) 01/2022 - 02/2012
11	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2022 - 12/2002
5	Disseminated Intravascular Coagulation 08/2021 - 02/2011
5	Hypoprothrombinemias (Prothrombin Deficiency) 03/2021 - 04/2013
4	Venous Thromboembolism 07/2022 - 01/2006
4	Atrial Fibrillation 01/2022 - 10/2008
4	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 03/2006
4	Wounds and Injuries (Trauma) 01/2020 - 02/2011
3	Cerebral Infarction 09/2018 - 05/2004
3	Thromboembolism 07/2018 - 11/2005
3	Stroke (Strokes) 10/2015 - 09/2007
2	Hepatocellular Carcinoma (Hepatoma) 11/2018 - 02/2012
2	Anemia 09/2018 - 01/2016
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2015 - 10/2014
2	Hemorrhagic Stroke 10/2015 - 10/2014
2	Multiple Organ Failure (MODS) 07/2013 - 12/2012
1	Thrombophilia 10/2021
1	COVID-19 08/2021
1	Infections 03/2021
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2021
1	Stomach Neoplasms (Stomach Cancer) 11/2018
1	Ischemic Stroke 09/2018
1	Purpura 04/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2016
1	Esophageal Neoplasms (Esophageal Cancer) 04/2016
1	Neoplasms (Cancer) 04/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Liver Failure 01/2016
1	Rare Diseases (Rare Disease) 01/2016
1	Human Influenza (Influenza) 04/2014
1	Respiratory Insufficiency (Respiratory Failure) 12/2013
1	Primary Myelofibrosis (Myelosclerosis) 12/2013
1	Post-Cardiac Arrest Syndrome 07/2013
1	Multiple Myeloma 04/2013
1	Obesity 02/2013
1	Insulin Resistance 02/2013

Drug/Important Bio-Agent (IBA)

10	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2021 - 10/2009
9	Antiphospholipid AntibodiesIBA 01/2021 - 01/2004
9	Factor VIII (Coagulation Factor VIII)IBA 04/2020 - 03/2008
8	AnticoagulantsIBA 01/2022 - 08/2014
7	Prothrombin (Factor II)IBA 01/2020 - 03/2006
6	AutoantibodiesIBA 01/2022 - 12/2002
6	Thrombin FDA Link 01/2020 - 01/2006
6	Hemostatics (Antihemorrhagics)IBA 01/2019 - 03/2008
5	Anticardiolipin AntibodiesIBA 05/2022 - 12/2002
5	AntibodiesIBA 05/2022 - 08/2009
4	AntithrombinsIBA 07/2022 - 10/2008
4	Dacarbazine (DIC)FDA LinkGeneric 08/2021 - 12/2012
4	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 08/2014
4	PhosphatidylserinesIBA 01/2016 - 03/2006
4	FibrinIBA 03/2015 - 02/2011
3	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2009
3	Immunoglobulin G (IgG)IBA 01/2022 - 03/2006
3	Protein SIBA 04/2021 - 10/2006
3	Protein CIBA 01/2021 - 11/2005
3	Rituximab (Mabthera)FDA Link 11/2018 - 10/2004
3	Leukocyte Elastase (Neutrophil Elastase)IBA 07/2013 - 02/2011
3	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 12/2012 - 06/2010
3	Fibrinolysin FDA Link 12/2012 - 09/2009
2	Glycoproteins (Glycoprotein)IBA 05/2022 - 12/2002
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 10/2015
2	Fibrin Fibrinogen Degradation ProductsIBA 08/2021 - 02/2011
2	Factor VIIa (Activated Factor VII)IBA 01/2019 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 09/2018 - 01/2016
2	Prednisolone (Predate)FDA LinkGeneric 04/2016 - 12/2013
2	recombinant FVIIa (rFVIIa)FDA Link 01/2016 - 12/2013
2	N(4)-oleylcytosine arabinosideIBA 10/2015 - 10/2014
2	ThrombomodulinIBA 10/2014 - 06/2010
2	Heparin (Liquaemin)FDA LinkGeneric 08/2014 - 01/2006
2	fibrin fragment D (D-dimer)IBA 02/2011 - 09/2009
2	AntigensIBA 06/2010 - 01/2004
2	Dabigatran FDA Link 10/2008 - 09/2007
2	Endothelial Protein C ReceptorIBA 12/2006 - 11/2005
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2005 - 01/2004
2	beta 2-Glycoprotein I (Apolipoprotein H)IBA 05/2004 - 12/2002
1	formycin diphosphate (FDP)IBA 08/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	Nucleosomes (Nucleosome)IBA 01/2020
1	Inosine Triphosphate (ITP)IBA 04/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Factor Xa InhibitorsIBA 10/2015
1	Neuraminidase (Sialidase)IBA 04/2014
1	prothrombin complex concentrates (PPSB)IBA 12/2013
1	Thalidomide (Thalomid)FDA Link 12/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013
1	Thromboplastin (Tissue Factor)IBA 06/2013
1	Bence Jones ProteinIBA 04/2013
1	CytokinesIBA 02/2013

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2006
1	Perioperative Period 03/2022
1	Gastrectomy 11/2018
1	Nephrectomy 04/2016
1	Radiotherapy 04/2016
1	Cesarean Section (Caesarean Section) 01/2016
1	Erythrocyte Transfusion 01/2016